127 related articles for article (PubMed ID: 28831541)
1. Durable remission is achievable with localized treatment and reduction of immunosuppression in limited stage EBV-related plasmablastic lymphoma.
Phipps C; Yeoh KW; Lee YS; Nagarajan C; Gopalakrishnan S; Ho LP; Hwang WYK; Goh YT; Grigoropoulos NF
Ann Hematol; 2017 Nov; 96(11):1959-1960. PubMed ID: 28831541
[No Abstract] [Full Text] [Related]
2. IgA plasmablastic large B-cell lymphoma.
Roncati L; Maiorana A
Diagnosis (Berl); 2017 Jun; 4(2):105-107. PubMed ID: 29536914
[No Abstract] [Full Text] [Related]
3. Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases.
Liu M; Liu B; Liu B; Wang Q; Ding L; Xia C; Dong L
Oncol Rep; 2015 Apr; 33(4):1615-20. PubMed ID: 25695332
[TBL] [Abstract][Full Text] [Related]
4. Fistulizing Epstein-Barr virus-positive plasmablastic lymphoma in an HIV-positive man.
Rangel J; Novoa R; Morrison C; Frank D; Kovarik C
Br J Dermatol; 2016 Feb; 174(2):398-401. PubMed ID: 26286218
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases.
Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S
Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616
[TBL] [Abstract][Full Text] [Related]
6. Successful cord blood transplantation for an HIV-negative patient with refractory plasmablastic lymphoma.
Nishi K; Mitani S; Hatanaka K; Imada K
Ann Hematol; 2017 Jun; 96(6):1057-1058. PubMed ID: 28293711
[No Abstract] [Full Text] [Related]
7. [Spontaneous regression of immunodeficiency associated plasmablastic lymphoma related to methotrexate after decrease of dosage].
García-Noblejas A; Velasco A; Cannata-Ortiz J; Arranz R
Med Clin (Barc); 2013 Jun; 140(12):569-70. PubMed ID: 23177304
[No Abstract] [Full Text] [Related]
8. Plasmablastic lymphoma: An update.
Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
[TBL] [Abstract][Full Text] [Related]
9. CD138- Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature.
Choudhuri J; Pan Z; Yuan J; Chen M; Wu X; Zheng G; Zhao C; Yuan Y; Agarwal B; Liu J; Ma MY; Wang Y; Shi Y
Arch Pathol Lab Med; 2023 Jun; 147(6):643-654. PubMed ID: 36161544
[TBL] [Abstract][Full Text] [Related]
10. Plasmablastic lymphoma presenting as a large intracardiac mass and bilateral pleural effusions.
Qing X; Enbom E; Qing A; French S; Cai J
Exp Mol Pathol; 2016 Feb; 100(1):79-81. PubMed ID: 26607603
[TBL] [Abstract][Full Text] [Related]
11. Violaceous nodules in an HIV-positive man.
Scott BL; Dominguez AR; Nguyen KD
Dermatol Online J; 2020 Feb; 26(2):. PubMed ID: 32239893
[TBL] [Abstract][Full Text] [Related]
12. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma.
Roychowdhury S; Peng R; Baiocchi RA; Bhatt D; Vourganti S; Grecula J; Gupta N; Eisenbeis CF; Nuovo GJ; Yang W; Schmalbrock P; Ferketich A; Moeschberger M; Porcu P; Barth RF; Caligiuri MA
Cancer Res; 2003 Mar; 63(5):965-71. PubMed ID: 12615710
[TBL] [Abstract][Full Text] [Related]
13. Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome.
Fakhri B; Cashen AF; Duncavage EJ; Watkins MP; Wartman LD; Bartlett NL
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e532-e535. PubMed ID: 31279773
[No Abstract] [Full Text] [Related]
14. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
[TBL] [Abstract][Full Text] [Related]
15. Relapse of Plasmablastic Lymphoma With Cutaneous Involvement in an Immunocompetent Male.
Shwe S; Sharma AA; Lee BA; Smith JE
Ear Nose Throat J; 2022 Jun; 101(5):NP222-NP225. PubMed ID: 32955361
[TBL] [Abstract][Full Text] [Related]
16. Primary central nervous system plasmablastic lymphoma in an HIV-positive patient.
Rhoades R; Gong J; Palmisiano N; Alpdogan O
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30872336
[TBL] [Abstract][Full Text] [Related]
17. EBV positive mucocutaneous ulcer with plasmacytic/plasmablastic differentiation and MYC rearrangement: a diagnostic challenge and a mimic of plasmablastic lymphoma.
Chen BJ; Chiang WF; Chen TS; Kao HJ; Chuang SS
Pathology; 2019 Oct; 51(6):648-650. PubMed ID: 31472984
[No Abstract] [Full Text] [Related]
18. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders.
Borenstein J; Pezzella F; Gatter KC
Histopathology; 2007 Dec; 51(6):774-7. PubMed ID: 17944927
[TBL] [Abstract][Full Text] [Related]
19. Epstein--Barr virus-associated B-cell lymphoma in the setting of iatrogenic immune dysregulation presenting initially in the skin.
Verma S; Frambach GE; Seilstad KH; Nuovo G; Porcu P; Magro CM
J Cutan Pathol; 2005 Aug; 32(7):474-83. PubMed ID: 16008691
[TBL] [Abstract][Full Text] [Related]
20. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.
Loghavi S; Alayed K; Aladily TN; Zuo Z; Ng SB; Tang G; Hu S; Yin CC; Miranda RN; Medeiros LJ; Khoury JD
J Hematol Oncol; 2015 Jun; 8():65. PubMed ID: 26055271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
